The World Health Organization simplifies the names of COVID-19 variants; updated Equal Employment Opportunity Commission guidance suggests employers can mandate COVID-19 vaccines; study finds a record 1.1 billion smokers were reported worldwide in 2019.
A new analysis reveals penalties levied under a CMS program to improve the quality of care at dialysis centers did not lead to significant change.
According to researchers, type 2 inhibitors do not seem to result in persistence of disease. In one mouse model, the inhibitor type was shown to also have a greater effect on disease biology.
Researchers outlined novel approaches to prevent and manage cytokine release syndrome (CRS), which occurs frequently in patients receiving chimeric antigen receptor T-cell therapy.
Patients who undergo cancer screenings, even when asymptomatic, experience short-lived psychosocial outcomes, such as anxious symptoms, distress, and worry.
New studies evaluate the impact of age on overall survival in adolescents and young adults (AYAs) with chronic lymphocytic leukemia, as well as response rates of rituximab in 2 combination regimens for hairy-cell leukemia and follicular lymphoma.
Highlighting the latest ophthalmology-related news reported across MJH Life Sciences™.
Many patients experience excessive daytime sleepiness (EDS) despite treatment for obstructive sleep apnea (OSA) and may benefit from wake-promoting drugs.
Rachael McCann, senior director at Willis Towers Watson, speaks of the greater need for mental health and well-being resources from employers to address caregiving demands amid the pandemic.
Christine Ko, MD, professor of dermatology and pathology at Yale University, reflects on her use of telehealth and how it allowed her to establish and maintain emotional connections with her patients, all at high risk of skin cancer.
Patient social cognition remained stable over 3 years, but its correlation with structural damage in the brain changed over time.
Both conditions involve a genetic predisposition as well as immune pathways that are triggered by environmental factors.
Some consider patients with type 2 diabetes (T2D) and chronic kidney disease poor candidates for metformin monotherapy due to the risk of lactic acidosis. However, new research finds patients who can tolerate the drug can gain similar benefits with or without kidney disease.
Patients with post–COVID-19 symptoms for at least 4 weeks should be assessed for pulmonary, cardiac, neurocognitive, and psychiatric complications and referred to a specialized clinic, a recent study notes
Ryan Bosch, MD, FACP, founder and president of Socially Determined, outlines steps for improving health literacy.
The study portrays the intense need for daily care experienced by children with aromatic L-Amino acid decarboxylase deficiency (AADC-d) and their families.
The exploration of the MAPK pathway has come as researchers look for new therapeutic targets for acute myeloid leukemia (AML), which still faces resistance to novel treatments like FLT3 inhibitors and subsequent relapses.
Humana's Bold Goal program allowed the health care giant to test new delivery models that it used to address loneliness and food insecurity during COVID-19.
The increase in hospitalization risk seen with Vascepa was small vs the survival gains seen from decreased rates of heart attack, stroke, and revascularization, noted Deepak L. Bhatt, MD, MPH, Brigham and Women’s Hospital Heart & Vascular Center.
A reported association between sex and mild ABCA4 alleles among patients with Stargardt disease did not hold up upon reevaluation.
An overview of the latest news in Parkinson disease reported across MJH Life Sciences™.
In the June 5, 1981, issue of the Morbidity and Mortality Weekly Report from the CDC, a brief 3-page report appeared describing 5 rare cases of Pneumocystis carinii pneumonia among 5 homosexual men in Los Angeles. Our full Q&A with the lead author on that report, Michael Gottlieb, MD, will appear next week. Below is a video preview.
As working women have been disproportionately impacted by COVID-19, solutions to address what has been coined a “she-cession” include targeted communications, flexible work schedules, and increased education/tutoring resources.
Production will begin within weeks on the GlaxoSmithKline/Sanofi COVID-19 vaccine candidate; nearly 3 of every 4 people who had severe cases of COVID-19 experience at least one long-term symptom; US colleges and universities report stark rise in applications in the public health field.
Here are some of the latest developments in multiple sclerosis (MS) from our sister publication, NeurologyLive®.
Abstracts from the ATS 2021 International Conference addressed patient decision-making frameworks for seeking care for chronic obstructive pulmonary disease (COPD) and tactics used to assist hospitals in implementing readmission reduction plans.
A phase 3 trial explored which treatment option for pemphigus vulgaris, a rare skin disease, resulted in better outcomes after 52 weeks.
Methotrexate reduces cardiovascular risk in patients with inflammatory disease but not in the general population.
Researchers underscored the importance of addressing these barriers, as artificial intelligence may offer improvements in clinical decision making, broaden access to care, and improve clinical efficiency.
A review detailed the initial steps taken into personalized therapeutic options for psoriatic arthritis.
